Synthesis of pH-degradable polyglycerol-based nanogels by iEDDA-mediated crosslinking for encapsulation of asparaginase using inverse nanoprecipitation by Oehrl, Alexander et al.
INVITED ARTICLE
Synthesis of pH-degradable polyglycerol-based nanogels
by iEDDA-mediated crosslinking for encapsulation of asparaginase
using inverse nanoprecipitation
Alexander Oehrl1 & Sebastian Schötz1 & Rainer Haag1
Received: 20 November 2019 /Revised: 14 May 2020 /Accepted: 14 May 2020
# The Author(s) 2020
Abstract
Biocompatible, environmentally responsive, and scalable nanocarriers are needed for targeted and triggered delivery of therapeutic
proteins. Suitable polymers, preparation methods, and crosslinking chemistries must be considered for nanogel formation.
Biocompatible dendritic polyglycerol (dPG) is used in the mild, surfactant-free inverse nanoprecipitation method for nanogel
preparation. The biocompatible, fast, and bioorthogonal inverse electron demand Diels-Alder (iEDDA) crosslinking chemistry is
used. In this work, the synthesis of pH-degradable nanogels, based on tetrazine, norbonene, and bicyclo[6.1.0]nonyne (BCN)
functionalized macromonomers, is reported. The macromonomers are non-toxic up to 2.5 mg mL−1 in three different cell lines.
Nanogels are obtained in the size range of 47 to 200 nm and can be degraded within 48 h at pH 4.5 (BA-gels), and pH 3 (THP-gels),
respectively. Encapsulation of asparaginase (32 kDa) yield encapsulation efficiencies of up to 93% at 5 wt.% feed. Overall, iEDDA-
crosslinked pH-degradable dPG-nanogels from inverse nanoprecipitation are promising candidates for biomedical applications.
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Introduction
Modern medicine has a high demand for new and smart
nanocarrier systems for drug delivery, that improve pharma-
cokinetics, permit the use of less overall drug, thus reduce side
effects, and lead to prolonged drug circulation time, and can
deliver their cargo specifically to diseased tissue and not to
healthy tissue [1]. Additionally, these carrier systems must be
biocompatible and either biodegradable or be easily excreted
by the body after delivering their cargo [2, 3]. Any degrada-
tion products and metabolites must be non-toxic. Attempts
have been made to design such nanocarriers for a variety of
drugs. In the class of hydrophobic drugs, there are already
some examples on the market, such as liposomal formulations
of the anticancer drugs doxorubicin (Doxil®) and
daunorubicin (DaunoXome®), and micellar estradiol
(Estrasorb™) [4]. However, liposomal formulations cannot
be considered smart or responsive carriers, as they lack the
structural properties to respond to external stimuli. For the
more sensitive drugs, such as therapeutic proteins, liposomal
formulations are not very suitable. The detergent nature of the
liposomes can disrupt the natural folding of the proteins and
thus lead to a loss of function. However, especially this type of
drug needs improved delivery systems. Proteins are usually
injected intravenously to the body, due to low stability in the
strongly acidic environment of the stomach or due to very low
absorption within the small intestine [5]. In the blood stream,
the mononuclear phage system (MPS), a part of the immune
system, effectively removes foreign substances from the body.
Proteins are easily recognized by the MPS and are thus elim-
inated quite fast [4, 6, 7]. Apart from the MPS, small proteins
are also excreted via the kidney if their molecular weight is
below the renal threshold of 45 kDa or hydrodynamic diame-
ter of 5.5 nm [8–10]. This shows that nanocarriers are needed
for protein delivery, which are able to increase the total mo-
lecular weight of the therapeutics to prolong circulation times
and offer evasion from theMPS clearance. Currently, the only
type of carriers that fulfill these criteria and are on the market,
are polyethylene glycol (PEG) protein conjugates. PEG is a
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hydrophilic and size-tunable, biocompatible polymer that is
attached randomly, or site specific to the protein. This in-
creases the total molecular weight above the renal threshold
and leads to increased circulation times and reduced clearance
through the MPS [11–13]. However, recently PEG has shown
to be able to induce immune responses in some patients, lead-
ing to reduced effectivity of the treatment [14, 15].
Furthermore, targeted delivery is not possible with PEG con-
jugation and can also reduce the activity of the protein that it is
conjugated to. Thus, alternatives that provide the same advan-
tages as PEG, but additionally also allow for a targeted deliv-
ery and release of the protein are needed.
Alternatively nanogels consist of hydrophilic polymer net-
works in the size range of 10 to 1000 nm and offer a hydrophilic
environment that shields any cargo encapsulated inside
[16–21]. The properties of these gels can be tuned, based on
the polymers that are used for the network formation. A variety
of options exist and have been intensively studied. Natural
polymers such as alginate [22], dextran [23], and chitosan
[24] have been used for nanogel preparation. However, synthet-
ically easily accessible polymers such as PEG [25], copolymers
of polylactic and glycolic acid (PLA/PLA-co-PGA) [26], linear
polyglycerol (lPG) [27], and dendritic polyglycerol (dPG)
[27–30] have also been successfully used for nanogel forma-
tion. The introduction of environmentally responsive groups,
such as pH-sensitive acetals [31–33], or redox-sensitive
disulfides [16, 34] can then be used for the preparation of de-
gradable nanogels. For example, within endosomes and lyso-
somes, the pH value drops to values between 4 and 6 [35].
Beside network material, the preparation method also has a
big influence on the suitability of the carrier for biomedical ap-
plications. Nanogels have been prepared by methods such as
micro- and miniemulsion polymerization [23, 36–38].
However, the use of surfactants, heat, and ultrasound can be
detrimental for the encapsulation of sensitive biotherapeutics.
Furthermore, surfactants are sometimes hard to remove and can
have a negative impact on cell viability and applicability in vitro
and in vivo.
Technologies such as the nanoprecipitation method, where
nanoparticles are formed by precipitation in their correspond-
ing non-solvent water, have been adjusted to hydrophilic
macromonomers [39–41]. This inverse nanoprecipitation
leads to hydrophilic nanogels by precipitation of the
macromonomers in solvents like acetone. Thus, very mild
conditions for the encapsulation of proteins are present, as
no surfactants or ultrasound are used [28, 30].
For the inverse nanoprecipitation method, usually
macromonomers are used that crosslink in situ during the pre-
cipitation process. In order to have a reasonably fast gelation,
the type of crosslinking chemistry plays a major role for suc-
cessful preparation of nanogels. Suitable chemistries include
the click-type copper-catalyzed azide alkyne cycloaddition
(CuAAC) [30], the strain-promoted version of CuAAC
(SPAAC) [27], thiol-Michael addition [42], and inverse elec-
tron demand Diels-Alder (iEDDA). CuAAC is suitable for gel
formation; however, the toxic copper ions are hard to remove
and can have toxicity in vivo. thiol-Michael addition is fast and
scalable, however, not suitable for proteins containing thiols, as
a cross-reactivity exists. SPAAC offers a fast gelation, as well
as very low cross-reactivity with free thiols. However, the syn-
thetic precursors are expensive and exhibit low-yielding, long
synthetic procedures. In contrast, iEDDA reactions between
tetrazine derivatives and dienophiles are so fast and
bioorthogonal [43–46] that they have been used for fluorescent
labeling of antibodies [47], DNA-tagging [48], and even cell
labeling [49]. The synthetic precursors are inexpensive and pre-
pared in a straightforward manner. Depending on the applica-
tion, one can choose between different reactivities and thus
gelation times. As there are no side reactions with biological
systems, this method is one of the most bioorthogonal reactions
available so far. Furthermore, no toxic catalysts, such as copper
ions, are needed, which makes iEDDA a very promising cou-
pling strategy for the preparation of biocompatible nanogels.
We present the synthesis of new pH-cleavable
macromonomers based on the biocompatible and easy to
functionalize dPG [12, 50–52] with methyl-tetrazine and the
dienophiles norbonene and bicyclo[6.1.0]non-4-yne (BCN) as
iEDDA reactive functional groups. pH degradability is intro-
duced by incorporation of benzacetal (BA) and tetrahydropyran
(THP)–based acetals into the macromonomers which cleave at
pH values of 5 and 3, respectively. The macromonomers are
characterized by NMR, IR, and DLS and tested regarding their
ability to form stable nanogels during inverse nanoprecipitation in
acetone under various reaction conditions. dPG-BA-norbonene
and dPG-THP-norbonene are used for encapsulation of the ther-
apeutic protein asparaginase with excellent encapsulation effi-
ciencies of up to 93%. TheBA-based gels are cleaved completely
within 48 h at pH 4.5, while the THP-based gelswere degraded at
pH 3 within 48 h. The macromonomers were tested in a cell
viability assay with three different cell lines and did not show
toxicity up to about 2.5 mg mL−1.
The fast and efficient synthetic route to pH-cleavable
macromonomers with iEDDA reactive groups, as well as the
stable and scalable nanogels that are obtained from them,
while avoiding the drawbacks of toxic catalysts or side reac-
tivity in other crosslinking strategies, makes this a nanocarrier
system with potential biomedical application.
Materials and methods
Materials
Ethyl acetate, n-pentane, and diethyl ether were obtained from
the technically pure solvents by distillation before use. Dry
DCM and THF were used from a SPS-800-type MBRAUN
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solvent drying system. Acetone and DCM (HPLC grade) were
used without further purification. Dry methanol and DMF
were purchased from Acros and Fischer Chemical. All other
chemicals and deuterated solvents were obtained from Sigma-
Aldrich, Acros, Merck, and Fisher Chemicals and were used
as without further purification. Thin layer chromatography
(TLC) was performed on silica gel–coated aluminum plates,
serving as stationary phase (silica gel 60 F254 from
Macherey-Nagel). Identification of analytes was done by
UV-irradiation (λ = 254 nm) of the TLC plates or by treatment
with a potassium permanganate–based (100 mL deionized
water, 200 mg potassium permanganate) or anis aldehyde–
based staining solution (450 mL EtOH, 25 mL anis aldehyde,
25 mL conc. sulfuric acid, 8.0 mL acetic acid). Column chro-
matography was performed with silica gel (Macherey-Nagel,
grain size 40–63 μm, 230–400 mesh) as stationary phase and
the indicated eluent mixtures as the mobile phase.
Analytical methods
IR spectra were recorded on a JASCO FT/IR-4100 spectrom-
eter. The characteristic absorption bands are given in wave
numbers. 1H NMR spectra were recorded at 300 K on Joel
ECX 400 400 MHz and AVANCE III (700 MHz) instru-
ments. Chemical shifts δ are indicated in parts per million
(ppm) relative to tetramethyl silane (0 ppm) and calibrated
as an internal standard to the signal of the incompletely deu-
terated solvent (CDCl3: δ = 7.26 ppm, MeOD: δ = 3.31 ppm).
Coupling constants J are given in Hertz (Hz). 13C NMR spec-
tra were recorded at 300 K on AVANCE III instruments (176
MHz). Chemical shifts δ are given in ppm relative to
tetramethyl silane (0 ppm) and calibrated as an internal stan-
dard to the signal of the incompletely deuterated solvent
(CDCl3: δ = 77.16 ppm, MeOD: δ = 49 ppm). Coupling con-
stants J are given in Hertz (Hz). The spectra are decoupled
from proton broadband. DLS and Zeta potential were mea-
sured on aMalvern zeta-sizer nano ZS 90with He–Ne laser (λ
= 532 nm) at 173° backscatter and automated attenuation at 25
°C. Three measurements were performed per sample, yielding
a mean size value plus an error estimate. Sample concentration
was kept at 1 mg mL−1. GPC was performed on an Agilent
1100 at 5 mg mL−1 using a pullulan standard, 0.1 M NaNO3
solution as eluent and a PSS Suprema column 10 μm with a
flow rate of 1 mL min−1. Signals were detected with an RI
detector.
Precursors and macromonomers
All air- and moisture-sensitive reactions were carried out in
flasks in an inert atmosphere (argon) using conventional
Schlenk techniques. Reagents and solvents were added via
argon-rinsed syringes. Solids were added in argon counter-
flow as solutions in the corresponding solvent.
The synthesis of the literature known precursors is de-
scribed in the Supporting Information, showing the modified
procedures.
2-(Azidomethyl)-3,4-dihydro-2H-pyran (5)
(3,4-Dihydro-2H-pyran-2-yl)methanol (1.58 g, 13.84 mmol)
and Et3N (2.10 g, 20,76 mmol, 2.88 mL) were dissolved in
DCM (25 mL). Methane sulfonyl chloride (1.74 g, 15.23
mmol, 1.18 mL) was added dropwise via syringe. The solu-
tion was stirred for 45 min at 0 °C. Saturated aqueous
NaHCO3 solution was added, phases were separated, and
the aqueous phase was extracted with DCM (3 × 25 mL).
The combined organic layers were dried with Na2SO4. The
solvent was removed under reduced pressure.
The crude product (2.84 g, 14.77 mmol) was dissolved in
DMF (20 mL), and NaN3 (9.60 g, 147.67 mmol) was added.
The solution was stirred at 55 °C for 3 days. Water (20 mL)
was added, the phases were separated, and the aqueous phase
was extracted with DCM (3 × 25 mL). The combined organic
layers were dried with Na2SO4. The solvent was removed
under reduced pressure. The crude product was purified by
column chromatography (pentan/EtOAc, 10:1) to give the
product (30) (1.91 g, 13.76 mmol, 93 % over 2 steps) as a
colorless oil.
1H–NMR (400 MHz, CD3OD) δ = 6.38 (d, J = 6.2 Hz, 1 H, H–
olefin–O), 4.74–4.72 (m, 1 H, H–olefin), 4.01–3.96 (m, 1 H,
H–tertiary), 3.48–3.32 (m, 2 H, H–CN3), 2.16–1.58 (m, 4 H,
H–ring) ppm.
dPG-THP-azide5%
dPG (0.12 g, 1.44 mmol) was dried under HV at 70 °C over-
night and dissolved in dry DMF (10 mL). The DHP-azide (5)
(0.02 g, 0.15 mmol) was dissolved in dry DMF (5 mL) and
added to the dPG–solution via syringe, and p-TSA (1.90 μg,
0.01 mmol) was added. The resulting solution was stirred at
room temperature overnight. After quenching with a small
excess of NEt3, the crude product was constricted under re-
duced pressure and dialyzed against H2O andmethanol 1:1 for
4 days and methanol for 3 days (MWCO = 1 kDa). The prod-
uct was obta ined as methanol ic solu t ion (5 .0%
functionalization, 85%).
1H–NMR (700 MHz, CD3OD) δ = 4.59–4.53 (m, 1 H, H–
C2H2N3), 4.21–14 (m, 1 H, H–C2H2–carbamate), 4.04
(dPG–backbone), 3.33–3.20 (m, 2 H, H–C–carbamate),
1.99–1.39 (m, 6 H, H–ring) ppm.
13C–NMR (176 MHz, CD3OD) δ = 101.4, 80.0, 79.9, 79.5, 79.3,
79.1, 74.1, 74.0, 72.6, 72.5, 72.2, 70.7, 70.67, 64.5, 64.4, 33.1,
29.1 ppm.
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IR (ATR) ν̃ = 3375, 2919, 2871, 2357, 2332, 2099, 1649, 1450,
1324, 1300, 1261, 1067 cm−1.
EA (C66H31N3O42) calc. C (48.37%), found C (49.46%); calc. N
(2.56%), found N (2.62%), calc. H (8.06%), found H (8.47%).
dPG-THP-amine5%
The dPG-THP-azide (1.67 g, 22.21 mmol, 1.13 mmol azide)
was dissolved in THF (70 mL). Distilled water (80 mL) and
PPh3 (3.50 g, 13.33 mmol) were added, and the solution was
stirred for 7 days at room temperature. THF was removed
under reduced pressure and the crude product was filtered.
The filtrate was constricted under reduced pressure. The crude
product was dialyzed against methanol for 5 days (MWCO =
1 kDa). The product was obtained as a methanolic solution
(5.0% functionalization, 95%).
1H–NMR (700 MHz, CD3OD) δ = 4.76–4.65 (m, 2 H, H–acetal),
4.24–4.03 (m, 2 H, H–C2H6N), 4.00–3.43 (dPG–backbone),
2.96–2.68 (m, 2 H, H–tertiary), 2.02–1.17 (m, 6 H, H–ring)
ppm.
13C–NMR (176 MHz, CD3OD) δ = 170.3, 142.7, 103.3, 81.7,
81.4, 80.2, 79.9, 73.98, 74.0, 73.0, 72.4, 72.2, 71.0, 70.7,
70.7, 64.5, 64.4, 62.8, 49.4 ppm.
IR (ATR) ν̃ = 3359, 2913, 1871, 2380, 1650, 1456, 1327, 1067,
1030, 931, 866. 748 cm−1.
General procedure for dPG-dienophiles
All dPG-dienophiles were synthesized according to the same
general procedure. As an example, dPG-BA-norbonene is de-
scribed in detail.
dPG-BA-norbonene8% (MM4)
Dry DMF (7.50 mL) was added to a methanolic solution of
dPG–benzacetal-amine (10.00 mL, 0.062 g/mL). Methanol
was removed under reduced pressure. Fresh dry DMF (7.50
mL) was added, the solution was constricted under reduced
pressure to 15 mL, and Et3N (0.18 g, 1,83 mmol, 0.25 mL)
was added. Norbonene active carbonate (2) (0.19 g, 0.67
mmol) was dissolved in DMF (10 mL), and the solution was
added dropwise via syringe to the dPG–amine solution. The
resulting reaction mixture was stirred at room temperature
overnight. The crude product was dialyzed against a mixture
of water and acetone (1:1) and methanol for 4 days (MWCO =
1 kDa). The product was obtained as a yellow methanolic
solution (88%, 7.5 % functionalization).
1H–NMR (700 MHz, CD3OD) δ = 7.49–7.35 (m, 2 H, H–aromat-
ic), 7.02–6.88 (m, 2 H, H–aromatic), 6.20–6.06 (m, 1 H, H–
olefin), 5.99–5.84 (m, 1 H, H–olefin), 5.78–5.68 (m, 1 H, H–
acetal), 4.63–4.54 (m, 2 H, H–C–carbamate), 4.47–4.22 (m, 2
H, H–C–OPh), 4.11–3.44 (dPG–backbone), 3.32–3.28 (m, 2
H, H–C–NH), 2.91–2.85 (m, 1 H, H–ring), 2.85–2.80 (m, 1 H,
H–ring), 2.03–1.94 (m, 2 H, H–ring), 1.90–1.82 (m, 1 H, H–
ring), 1.42–1.14 (m, 2 H, H–aliphatic) ppm.
13C–NMR (176 MHz, CD3OD) δ = 161.4, 161.2, 159.2, 138.6,
138.0, 137.4, 133.3, 129.6, 129.3, 115.4, 105.6, 104.9, 81.4,
80.2, 79.9, 76.6, 74.1, 74.0, 73.0, 73.0, 72.6, 72.5, 72.4, 72.2,
71.0, 70.8, 69.2, 68.6, 66.7, 64.5, 64.4, 62.8, 50.4, 45.9, 45.1,
43.5, 42.8, 39.5, 38.9, 30.8, 30.4, 29.9 ppm. 48
IR (ATR) ν̃ = 3374, 2871, 1696, 1614, 1517, 1458, 1394, 1327,
1304, 1244, 1075, 977 cm−1.
EA (C847H1475N13O440) calc. C (53.88%), found C (53.29%);
calc. N (0.96%), found N (1.94%); calc. H (7.87%), found
(8.21%).
dPG-THP-norbonene5% (MM6)
DMF (10 mL), dPG-THP-NH2 (440 mg, 0.3 mmol NH2),
NEt3 (170 μL, 3 eq), BCN (132 mg, 0.42 mmol) in DMF (3
mL). The product was stored as the methanolic solution in the
freezer (5%, 91%).
1H–NMR (700 MHz, CD3OD) δ = 6.23–6.02 (m, 2 H, H-olefin),
3.95–3.54 (m, dPG–backbone, 2.94–0.61 (m, 6 H, aliphatic-
H).
13C–NMR (176 MHz, CD3OD) δ = 159.23, 138.54, 133.31,
98.72, 81.64, 81.43, 80.16, 79.89, 73.99, 72.96, 72.46,
72.23, 70.98, 70.68, 69.33, 64.42, 62.83, 50.37, 49.85,
45.12, 43.49, 42.86, 39.79, 39.50, 30.62, 29.88, 29.06,
24.55, 18.79.
dPG-THP-BCN5% (MM7)
DMF (10 mL), dPG-THP-NH2 (440 mg, 0.3 mmol NH2),
NEt3 (170 μL, 3 eq), BCN (144 mg, 0.45 mmol) in DMF (3
mL). The product was stored as the methanolic solution in the
freezer (5%, quantitative).
1H–NMR (700 MHz, CD3OD) δ = 3.96–3.55 (m, dPG–back-
bone), 2.44–0.73 (m, 11 H, aliphatic-H-BCN).
13C–NMR (176 MHz, CD3OD) δ = 157.96, 98.28, 80.25, 80.04,
78.82, 78.51, 72.62, 71.58, 71.07, 70.84, 69.61, 69.30, 67.87,
63.11, 63.03, 61.43, 48.46, 33.07, 28.85, 28.04, 23.72, 22.84,
20.63, 20.05, 17.62, 17.40.
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Inverse nanoprecipitation of macromonomers
General procedure The ratio of macromonomer A (dPG-
metTet) to macromonomer B (dPG-dienophile) was set to
1:1.5. Acetone was used as the non-solvent. Parameters, such
as solvent to non-solvent ratio (1:20–1:80) and water
quenching time Tq, water (0–120 min), were varied according
to the tables described in the “Results and discussion” section.
As an example, a general procedure for one set of parameters
is described in detail below.
Macromonomers A and Bwere stored as stock-solutions of
100 to 150 mg mL−1 in water. Aliquots were taken and sepa-
rately diluted with water to a final volume of 1 mL. For this,
15 μL of macromonomer A was diluted with 485 μL water
and 22.5 μL of macromonomer B with 477.5 μL water. Both
solutions were cooled in an ice bath to 4 °C. Macromonomer
A solution was added fast to solution B and vortexed for 5 s.
Then, the solution was added fast via syringe to a 60-mL glass
vial containing magnetically stirred acetone (40 mL) at 1200
rpm. The turbid dispersion was stirred for another 2 s and then
kept still for 10 min. The reaction was then quenched by the
addition of 20 μL of 2-(vinyloxy)ethan-1-ol. Water (1/3 of
acetone) was added after 30 min, and the acetone was re-
moved under reduced pressure. Purification was performed
by centrifugal filtration, using a membrane with a cutoff of 1
MDa and 3 consecutive washing steps with 10 mL distilled
water/PBS buffer each. Nanogels were obtained as stable dis-
persions in water and characterized using DLS, NTA, and
Zeta-potential measurements.
Co-precipitation of asparaginase
The inverse nanoprecipitation was performed as described in
“Inverse nanoprecipitation of macromonomers.” Two hun-
dred twenty-five microliters of a 1.11 mg/mL stock solution
of asparaginase was added to the dPG-metTet macromonomer
solution and thoroughlymixed. The total volume of water was
kept at 1 mL. 5 wt.% of asparaginase was encapsulated each
for dPG-norbonene-, dPG-BA-norbonene, and dPG-THP-
norbonene-NGs (n = 3). The gels were purified by centrifuga-
tion filtration, using filters with a molecular weight cut-off of 1
MDa at 234 rcf. The gel volume was reduced to 1 mL and
fresh PBS buffer was added (10 mL). Then, the volume was
reduced to 1 mL again and the whole process was repeated
three times to ensure the complete removal of the non-
encapsulated protein.
Protein content determination assay
A standard Pierce BCA assay kit was used for the determina-
tion of asparaginase content within the nanogels. Twenty-five
microliters of the purified nanogels was added to a 96-well
plate. Then, 200 μL of working reagent was added to each
well and the plate was shaken for 30 s on a plate shaker. The
plate was then incubated at 37 °C for 1 h. After cooling to
room temperature, the absorbance was measured at 562 nm on
a plate reader. Samples were recorded in triplicate and for
three independent gels of the same type. Calibration curves
were prepared for a dilution series of albumin and
asparaginase in the range of 0 to 1000 μg mL−1.
Concentrations of asparaginase in the samples were deter-
mined via the fitted standard curves of asparaginase
(Figure S4).
Degradation of nanogels
For the continuous degradation experiments, 100 μL of 2 mg/
mL was diluted with buffer to 200 μL total volume. For each
pH value, a different buffer was used. In the case of pH 7.4, a
10 mM PBS buffer; in the case of pH 4.5, 10 mM acetate
buffer; and in the case of pH 3, the same acetate buffer with
addition of 1 M HCl were used.
The solutions were placed in a disposable UV-cuvette and
measured continuously with a Malvern zeta-sizer nano ZS 90
with He–Ne laser (λ = 532 nm) at 173° backscatter and auto-
mated attenuation at 25 °C for 16 h.
For nanogels with protein content 333 μL of 1.1 mg/mL
nanogel dispersion were diluted with 500 μL of the buffer
solutions and agitated continuously with a vortex at lowest
agitation speed for 48 h. At 30 min, 1 h, 3 h, 5 h, 8 h, 24 h,
and 48 h, a sample of 70μLwas taken for each pH value, snap
frozen in liquid nitrogen, and stored at − 20 °C in the freezer.
Particle size distributions were measured for each time point
and pH value using a Malvern zeta-sizer nano ZS 90 with He–
Ne laser (λ = 532 nm) at 173° backscatter and automated
attenuation at 25 °C. A mean of three measurements is
reported.
Cell viability assay
Cell viability was determined using a CCK-8 Kit (Sigma-
Aldrich) according to the manufacturer’s instructions. A549,
HeLa, and MCF-7 cells were obtained from Leibniz-Institut
DSMZ - Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH and cultured in DMEM (A549 cells) or
RPMI 1640 (HeLa and MCF-7 cells) supplemented with 10%
(v/v) FBS, 100 U/mL penicillin, and 100 μg mL−1
streptomycin.
A549, HeLa, and MCF-7 cells were seeded in a 96-well
plate at a density of 5 × 104 cells/mL in 90 μL DMEM/RPMI
Medium per well over night at 37 °C and 5% CO2. Ten mi-
croliters of dPG-metTet or dPG-dienophile (solved in deion-
ized water) was added in serial dilutions including positive
(1% and 0.1% SDS) and negative controls (cell culture medi-
um and 10% H2O in cell culture medium) and incubated for
another 24 h at 37 °C and 5% CO2.
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Scheme 1 Synthetic overview for the different macromonomers. The
following conditions were used: (a) MsCl, NEt3, DMF, rt, overnight;
(b) NaN3, 60 °C, 3 days; (c) PPh3, water/THF, rt, 3 days; (d) 1, NEt3,
DMF, rt, overnight; (e) 2, NEt3, DMF, rt, overnight; (f) 5, HATU,
DIPEA, DMF, r t , overn igh t ; (g ) 1 - (3 -az idopropoxy) -4 -
(dimethoxymethyl)benzene, pTSA, DMF, 40 °C, overnight; and (h) 3,
pTSA, DMF, rt, overnight. Number of reactive groups not representative;
just for clearness
Scheme 2 Simplified overview on the inverse nanoprecipitation process; pH decrease leads to disintegration of the network and the release of the protein
cargo
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For background subtraction, also wells containing no cells
but only sample were used. After 24-h incubation, the CCK8
solution was added (10 μL/well) and absorbance (450 nm/650
nm) was measured after approximately 3-h incubation of the
dye using a Tecan plate reader (Infinite pro200, TECAN-
reader Tecan Group Ltd.).
Measurements were performed in triplicate and repeated
three times. The cell viability was calculated by setting the
non-treated control to 100% and the non-cell control to 0%
after subtracting the background signal using the Excel
software.
Results and discussion
Synthesis of precursors and macromonomers
The synthetic accessibility of macromonomers and precursors
for nanogel formation is quite important, as any useful appli-
cation needs scalable and high-yielding reactions. For the in-
verse nanoprecipitation itself, a highly efficient and
bioorthogonal crosslinking chemistry is needed. The iEDDA
crosslinking chemistry we used provides the efficient and fast
reaction to produce nanogels in a reliable fashion. The syn-
thetic focus of this work thus lies on the synthetic description
of the pH-cleavable THP linker that was used, to our knowl-
edge, for the first time and the different macromonomers that
were obtained from the dPG-benzacetal- and dPG-THP-amine
cores.
The second most important property for a biological appli-
cation is the biocompatibility of the synthetic polymers that
are used. Dendritic polyglycerol is a platform for straightfor-
ward post-modification and has already been shown to be
biocompatible [53]. The polymer itself can be obtained on a
multigram to kilogram scale and is easy to functionalize either
directly via the hydroxyl groups or by a short reaction se-
quence that leads to the dPG-amine derivative. This dPG-
amine can then be reacted with a large variety of molecules
to further introduce functionality to the polymer. In this way,
many different non-degradable macromonomers for iEDDA
can be generated in a straightforward and scalable fashion.
The synthetic routes for the activated carbonates of the
dienophiles (1 + 2), the methyl tetrazine carboxylic acid (3),
the benzacetal-azide precursor (4), and the DHP-azide (5) can
be found in Scheme S1 in the Supporting information. These
precursors were then used to functionalize dPG, as well as
dPG-amine to the corresponding macromonomers that were
used in this work. The synthetic routes are described in
Scheme 1.
Norbonene was chosen as the reactive dienophile because
its activated carbonate form can be obtained in a high-yielding
two-step reaction from the commercially available and quite
inexpensive precursor bicyclo[2.2.1]hept-5-ene-2-
carbaldehyde. The methyl tetrazine carboxylic acid (3) has
also been shown to be easily attached to the dPG-amine core
Table 1 Influence of water to
acetone ratio on the
hydrodynamic diameter of dPG-
BA-norbonene/dPG-metTet-NGs





1 1:1.5 5 1:80a 102 ± 2 0.03 ± 0.01
2 1:1.5 5 1:60 120 ± 2 0.02 ± 0.01
3 1:1.5 5 1:40 91 ± 1 0.04 ± 0.02
4 1:1.5 5 1:20 62 ± 1 0.08 ± 0.01
A = dPG-metTet; B = dPG-BA-norbonene. a Different container used for gelation compared with other water/
acetone ratios, Tq, chem = 10 min, Tq, water = 30 min
Table 2 Influence of water to
acetone ratio on the
hydrodynamic diameter of dPG-
BA-BCN/dPG-metTet-NGs





1 1:1.5 5 1:80a 94 ± 1 0.06 ± 0.01
2 1:1.5 5 1:60 147 ± 2 0.10 ± 0.01
3 1:1.5 5 1:40 88 ± 1 0.07 ± 0.01
4 1:1.5 5 1:20 47 ± 1 0.10 ± 0.01
A = dPG-metTet; B = dPG-BA-BCN. a Different container used for gelation compared with other water/acetone
ratios, Tq, chem = 10 min, Tq, water = 30 min
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via simple amide bond formation, and the corresponding
macromonomer is stable for extended periods of time in
MeOH and water.
BCN was used as a comparison to norbonene, as it can be
obtained from commercial sources, although the price is quite
high, and the synthetic route is low yielding and lengthy [54].
It is most commonly used in SPAAC click reactions in com-
bination with organic azides; however, it has some cross-
reactivity with thiols, limiting its biorthogonality.
In order to introduce pH degradability to the system, we
chose two different types of acetal linkers between the dPG
core and the dienophiles. The benzacetal (BA) linker (4) is
known to degrade at pH values below 5, and the cyclic aliphatic
acetal that is generated in macromonomers 6 and 7 can degrade
at pH values below 3. Synthetically, the BA precursor was
obtained in 4 steps and was directly attached to the dPG core
by trans-acetalization of the terminal 1,3 diols of the polymer to
form the cyclic aromatic acetal motif that can be seen in
Scheme 1. The precursor for the aliphatic acetal linking groups
can be obtained by modification of a common protecting group
for alcohols in organic synthesis, the DHP protecting group. A
slightly modified precursor is commercially available ((3,4-
dihydro-2H-pyran-2-yl)methanol). This was transformed in
two steps to the corresponding DHP-azide (5) which was then
attached to the dPG-core by an acid catalyzed addition reaction.
The polymer azides that were obtained in this fashion were
then reduced to the corresponding amines, using a Staudinger
reduction. The dPG-acetal amines are the platform for the
attachment of the activated carbonate forms of the
dienophiles. These dPG-acetal-dienophiles (MM4–MM7)
were obtained in high yields of 85 to > 99% applying the same
synthetic method for each macromonomer. This toolbox of
monomers was then characterized using NMR, IR, and
DLS. The degradable macromonomers were then employed
to produce nanogels via inverse nanoprecipitation in acetone.
Fig. 1 Size trend and
polydispersity of nanogels formed
from MM4 and MM5 with
varying water to acetone ratio
during inverse nanoprecipitation
Table 3 Influence of water quenching time on the hydrodynamic
diameter of dPG-BA-norbonene/dPG-metTet-NGs







1 1:1.5 5 60 88 ± 1 0.04 ± 0.01
2 1:1.5 5 30 92 ± 1 0.04 ± 0.01
3 1:1.5 5 10 75 ± 1 0.20 ± 0.01
4 1:1.5 5 5 nd nd
5 1:1.5 5 4 nd nd
A = dPG-metTet; B = dPG-BA-norbonene, nd = measurement quality
criteria not achieved due to very high polydispersity, V(H2O):V(acetone)
= 1:40, Tq, chem = 10 min
Table 4 Influence of water quenching time on the hydrodynamic
diameter of dPG-BA-BCN/dPG-metTet-NGs







1 1:1.5 5 30 73 ± 1 0.08 ± 0.01
2 1:1.5 5 40 65 ± 1 0.07 ± 0.01
3 1:1.5 5 50 62 ± 1 0.10 ± 0.01
4 1:1.5 5 60 72 ± 1 0.07 ± 0.01
A = dPG-metTet; B = dPG-BA-BCN, V(H2O):V(acetone) = 1:40, Tq,
chem = 10 min
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Nanogel preparation by inverse nanoprecipitation
In general, the inverse nanoprecipitation method works by injec-
tion of a solution of macromonomers in a suitable solvent, such
as water, into the corresponding non-solvent of said
macromonomers, in this case acetone. While the water is dis-
persed within the acetone, the insoluble macromonomers precip-
itate out of solution. First small aggregates are formed which,
with time, form larger and larger conglomerates. Due to the local
concentration of these macromonomers within the aggregates
being high, the reaction of the dienophiles with methyl tetrazin
proceeds very fast and thus leads to the crosslinking of the ag-
gregates to form a hydrophilic nanogel network. As time pro-
ceeds, the small gel networks come into contact and crosslink
further until almost all macromonomers are consumed, yielding
the stable dispersions of nanogels acetone. By the addition of
water, the gel formation is quenched, and upon removal of ace-
tone, the nanogels are obtained as stable dispersions in water.
The simplified process can be seen in Scheme 2 with dPG-BA-
norbonene and dPG-metTet as an example.
We studied the parameters that have the most influence on
nanogel formation with this type of macromonomers. It was
observed that the time when water is added to the reaction
mixture and the water/acetone ratio are the most influential
parameters on nanogel size.
As can be seen in Tables 1 and 2, we investigated the
influence of water to acetone ratios on nanogel size and poly-
dispersity for dPG-BA-norbonene and dPG-BA-BCN
nanogels, respectively.
The overall trend is summarized in Fig. 1.
It is evident that there is a trend towards smaller nanogels
when the ratio of water to acetone becomes bigger. This is
expected, as a higher water content increases the solubility of
the macromonomers in the mixture of water and acetone, thus
leading to smaller aggregates in the non-solvent. The ratio of
0.0125, however, is an outlier since more than one parameter
Fig. 2 Co-precipitation of asparaginase at 5 wt.% feed withMM1/MM3,
MM4/MM3, andMM6/MM3. a DLS data for a gel without (black) and
with asparaginase (red) present during gel formation (dPG-norbonene-
NG). b DLS data for a gel without (black) and with asparaginase (red)
present during gel formation (dPG-BA-norbonene-NG). cDLS data for a
gel without (black) and with asparaginase (red) present during gel forma-
tion (dPG-THP-norbonene-NG). d Encapsulation efficiency determined
by a BCA assay for gels with asparaginase and control gels without; the
readout of the control gels was subtracted from the values that were
determined for the gels containing asparaginase
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was changed. Instead of only changing the solvent to non-
solvent ratio, the geometry and total volume of the container
was altered at the same time (250 mL instead of 80 mL). Two
significant parameters are altered and thus lead to the outlying
point in the trend line. However, for a given set of parameters,
the nanogel production is reproducible. Moreover, the poly-
dispersity of the final nanogels in water is not significantly
influenced by the high ratios of water:acetone which offers
the opportunity to produce small nanogels without a negative
impact on the polydispersity of the gels and using relatively
low amounts of organic solvent, which simplifies the overall
process of nanogel production.
The second most influencing parameter we tested was the
time when water was added to the mixture in order to stop any
further crosslinking between already formed nanoaggregates.
The results for a variety of quenching times between 4 and
60 min are shown for dPG-BA-norbonene/dPG-metTet in
Table 3.
One can see that immediate quenching after 4 or 5 min
leads to a complete disruption of nanogel formation as the
resulting gel/macromonomer mixtures were so polydisperse
that they did not reach the measurement quality to report a
reliable value. After 10 min, the gel seemed to have formed;
however, the polydispersity was quite high compared with
other batches, which indicates that at this timepoint there are
still unreacted small aggregates present. After around 30 min,
the gel is fully formed and no significant change in nanogel
size can be observed. The polydispersity, however, reaches
very good values of below 0.05.
We decided to test only larger quenching times forMM5 as
it was evident that a real control over nanogel size using small
quenching times was not possible. The results for quenching
times between 30 and 60 min are summarized in Table 4.
As expected, the longer quenching times did not have an
influence on nanogel size as most of the crosslinking hap-
pened in the first few minutes. However, it also showed that
most of the reactive surface groups were consumed within the
first hour, which prevented bigger aggregates and possibly
complete precipitation of the nanogels. PDI values were also
not significantly affected using these quenching times and
stayed between 0.07 and 0.1.
The nanogels were obtained in a reproducible manner. We
thus chose the norbonene derivative to perform co-
precipitation of the therapeutic protein asparaginase.
Asparaginase encapsulation by co-precipitation
The protein asparaginase is used as a drug to treat acute lym-
phoblastic leukemia (ALL). A PEGylated version is available
on the market (Oncaspar®) [3].
5 wt.% of protein compared with the total amount of
macromonomers was chosen for encapsulation, without se-
verely impacting the polydispersity of the gels. However,
the size of the nanogels almost always increased to higher
Fig. 3 Degradation profiles of dPG-BA-norbonene- and dPG-THP-norbonene at pH 7.4, pH 4.5, and pH 3. a–c dPG-BA-norbonene-NG at pH 7.4, 4.5,
and 3. d–f dPG-THP-NG at pH 7.4, 4.5, and 3
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values when compared with gels that were produced without
the addition of a protein.
The norbonene derivatives of the macromonomers (MM1,
MM4, MM6) were used to perform the co-precipitation of
asparaginase, as the precursors are synthetically more accessible
compared with the BCN derivatives and should have negligible
reactivity towards biological systems. As a control we used
nanogels that were prepared without the addition of asparaginase
during nanoprecipitation. The results are summarized in Fig. 2.
It is evident that the co-precipitation of a protein shifted the
size of the resulting nanogels to higher values. We hypothesize
that this was due to interactions of the protein with the
macromonomers during the inverse nanoprecipitation process
which lead to the formation of bigger initial aggregates which
grew faster during the gel formation process, thus resulting in
bigger nanogels.
After a purification process, where the gels were washed in
a centrifugal filter with PBS, most of any free protein should
be removed from the gel dispersions. The gels were then test-
ed regarding their protein content, using a standard BCA assay
with a dilution series of free asparaginase as the standard curve
(Figure S4). Gels that were formed without the addition of
asparaginase were used as a control, and the OD values for
these gels were subtracted from the gels that contained
asparaginase. The results of the encapsulation efficiency can
be seen in Fig. 2d. All three types of gels, namely dPG-
norbonene, dPG-BA-norbonene-, and dPG-THP-norbonene
nanogels, reached very good encapsulation efficiencies of be-
tween 81 and 93%, showing the suitability of these
macromonomers to form gels that efficiently entrap
asparaginase within their gel network.
The pH degradability of the different types of acetal func-
tionalized nanogels was then tested at different pH values.
pH-triggered degradation of nanogels
In order to study the degradation behavior of the gels, we
added the different types of gels which contained asparaginase
to buffer at different pH values. Every group of gel was ex-
posed to pH 7.4, pH 4.5, and pH 3 at moderate agitation and
room temperature. The degradation was then followed over
the course of 48 h. At each time point a sample was taken and
snap frozen in liquid nitrogen to be later measured by DLS.
The results are shown in Fig. 3 and Figure S8.
At pH 7.4 (Fig. 3a, d) both gels do not show degradation at
all. Through the strong agitation, however, the particles tend
to aggregate and show a strong increase in polydispersity. In
terms of degradation, there was no significant amount of small
Fig. 4 Continuous degradation profile of dPG-BA-norbonene-NG at pH 4.5 in acetate buffer. Size by volume, Z-average, size by number, and PDI are
shown. The derived count rate is shown for comparison
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particles observable. However, at pH 4.5 nanogel degradation
was observed for the gel with BA linking groups (Fig. 3b). At
first, swelling of the nanogels was observed, which shifted the
distribution towards bigger size values, while only after 24 h
small particles appeared at around 20 nm in a mix with still
intact nanogels. After 48 h, however, most particles were in
the size range of around 20 nm. In contrast, even after 48 h no
degradation was observed for the aliphatic THP-acetal linker
containing gel (Fig. 3e). This was expected, as these kinds of
acetals degrade usually only at pH values of below 3.
At pH 3, the dPG-BA-norbonene NG (Fig. 3c) degraded
much faster than at pH 4.5. After already 3 h particles of
around 50 nm were observed and after 8 h mostly particles
of around 20 nm remained. At 48 h nearly all particles were
degraded to around 10 nm, which signaled the complete
breakdown of the gels into mostly macromonomers.
The dPG-THP-norbonene-NG at pH 3 in contrast to pH 4.5
started to degrade and showed smaller particles of around
50 nm after 8 h. After 48 h almost complete degradation to
particles of around 20 nm was observed.
In order to see amore detailed degradation profile of the dPG-
BA-norbonene-NGs, a continuous monitoring over the course of
18 h was performed. For this, a nanogel without protein was
degraded in acetate buffer at pH 4.5 within a DLS cuvette and
measured continuously while every measurement corresponds to
roughly 2 min. The results are shown in Fig. 4.
The black curve in every diagram corresponds to the de-
rived count rate. This was constantly decreasing over time,
which indicated less, and less particle counts over time.
However, over a long period of time of around 8 to 9 h, not
much change could be observed in the volume and number
distributions. If at all, there is a slight increase in size, probably
due to swelling of the gels. After around 9 h, the PDI value
slowly started to rise, which showed that a mixture of particles
must be present with a wider distribution of sizes. This could
also be observed in the size by volume and number distribu-
tions. From this point on, the size values continued to decrease
until at around 13 h the count rate became too low for the
measurement quality to obtain reliable results. This was indi-
cated by the fluctuation of measurement values and the strong
Fig. 5 Cell viability assay of all different macromonomers using three different cell lines, control: from left to right SDS (1%), medium (10%), water
(10%). a A549 cell line. b HeLa cell line. c McF7 cell line
730 Colloid Polym Sci (2020) 298:719–733
spreading of the distribution of values. However, at least a
trend could be observed, which showed that the gels
disintegrated between 9 and 14 h to values below 20 nm.
All in all, this shows that the gels based on the BA linkers
that were used can be degraded at pH values that can be found
in endosomes and lysosomes. At pH 7.4 all gels were stable
for extended periods of time, as can be seen in Figure S6. NTA
measurements of the same gels also confirmed that the particle
sizes obtained from DLS are comparable (Figure S7).
CCK8 cell viability test
For any application handling living cells or in vivo experi-
ments, it is necessary to know if the macromonomers that
are used are non-toxic to the cells at reasonable concentra-
tions. In the case of the nanogels we presented here, no free
macromonomers remain; however, for applications such as
microgelation and co-encapsulation of living cells, it is abso-
lutely mandatory to see if the macromonomers are toxic, be-
cause they come into direct contact with the cells they encap-
sulate. After gel formation the gels are mostly appearing as
hydrophilic networks, presenting a lot of hydroxyl groups and
it has been demonstrated before that nanogels, based on dPG,
do not impact the cell viability negatively within a certain
concentration range [55].
The results for three different cell lines are summarized in
Fig. 5.
All macromonomers did not have a big impact on cell
viability up to approximately a concentration of 156 μg
mL−1; however, dPG-THP-norbonene exhibited slight cyto-
toxicity at concentrations higher than this. The rest of the
macromonomers were non-toxic even up to concentrations
of 2.5 mg mL−1. This indicated that the macromonomers are
suitable even for applications with living cells.
Conclusion
We have shown the synthesis of different reactive
macromonomers for iEDDA click chemistry mediated produc-
tion of pH-degradable nanogels that are degraded at their acetal
linking points. Three different groups of nanogels were produced.
Non-degradable gels, degradable gels, based on an aromatic BA
linker, and degradable gels based on an aliphatic THP acetal were
obtained. The NGs were synthesized in the size range of 47–200
nm with excellent polydispersity indices of 0.1 and below.
Co-precipitation of the therapeutic protein asparaginase
showed excellent encapsulation efficiencies of between 81
and 93% for nanogels made from dPG-norbonene and dPG-
BA-norbonene, respectively.
Gels based on the aromatic BA linker were degraded at pH
values of 4.5, within 24 h, while THP-linked gels were not de-
graded at all at this pH. dPG-BA-norbonene gels were degraded
fast within 9 h at pH 3, and dPG-THP gels showed complete
degradation within 24 h at this pH showing the applicability of
the dPG-BA-dienophile gels for degradation within endosomal
to lysosomal pHwindows. All gels were stable in PBS at pH 7.4
for extended periods of time. The macromonomers used did not
show cell toxic effects up to about 2.5 mgmL−1, except for dPG-
THP-norbonene.
The low toxicity of the macromonomers, as well as the repro-
ducible gel formation within a reasonable size range and low
polydispersity, together with the excellent encapsulation efficien-
cy, makes the nanogels ideal for the delivery of therapeutic pro-
teins. As a future perspective, functionalization of the dPG-core
with targeting ligands could be performed, in order to obtain
nanocarriers that have active as well as passive targeting
properties.
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